How much did Immuneering raise?

Immuneering raised $20 Million in a funding round on October 4, 2019.

Who are the decision-makers at Immuneering?

Fundz holds 1 contact at Immuneering. Names and contact details are shown to Fundz members.

Immuneering Corp reported raising $20 Million in an initial SEC Form D filing, from an offering of $15 Million

PUBLIC · IMRXOct 04, 2019

Amount Raised

$20 Million

$20 Million sold, per SEC Form D (first sale Oct 4, 2019)

Round Type

Venture

CambridgeBiotechnologyHealthcareHealth CareMedicalTherapeutics

Quick answer

Immuneering raised $20 Million in a funding round, dated October 4, 2019. Immuneering is based in Cambridge, Massachusetts, United States.

How much did Immuneering raise?: Immuneering raised $20 Million in a funding round on October 4, 2019.
What does Immuneering do?: Immuneering is a clinical-stage oncology company focused on keeping cancer patients alive.
Where is Immuneering based and how big is it?: Immuneering is based in Cambridge, Massachusetts, United States.
Who are the decision-makers at Immuneering?: Fundz holds 1 contact at Immuneering. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Medical around the same time

Companies in the same sectors as Immuneering that raised within 45 days of this round, from Fundz verified event records.

Renibus Therapeutics raised $3.4M on September 23, 2019.
Vektor Medical raised $3.6M (Seed) on November 15, 2019.
Revolution Medicines raised $100M on November 15, 2019.
ISOThrive raised $4M on November 14, 2019.
Streamex Corp. raised $686K on November 5, 2019.
MindImmune Therapeutics raised $750K on November 1, 2019.

Who to call at Immuneering, and when

A new round usually means Immuneering is about to hire and buy. The teams that reach out first get the meeting.

An alert the day Immuneering raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Immuneering, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Immuneering. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Immuneering

Location

245 MAIN STREET, SECOND FLOOR

Cambridge, Massachusetts, United States

About

Immuneering is a clinical-stage oncology company focused on keeping cancer patients alive. The Company is developing an entirely new category of cancer medicines, Deep Cyclic Inhibitors. Immuneering’s lead product candidate, atebimetinib (IMM-1-104), is an oral, once-daily Deep Cyclic Inhibitor of MEK designed to improve durability and tolerability, and expand indications to include MAPK pathway-driven tumors such as most pancreatic cancers. Atebimetinib is currently in a Phase 2a trial in patients with advanced solid tumors including pancreatic cancer. The Company’s development pipeline also includes early-stage programs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Immuneering raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans

Related People

1 contact

Verified contacts5 people are listed at Immuneering. We don't have their email yet.See plans and pricing

Predictive Intelligence

Strategic

ML-powered predictions for Immuneering's next move

See what Strategic adds

Immuneering raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

Show me how a sales rep uses this Or see plans and pricing →

5 screens from a live account. No signup.